Department of Intensive Care, Centro Hospitalar Unimed de Joinville, Santa Catarina, Brazil.
Brazilian Research in Intensive Care Network, São Paulo, Brazil.
J Intensive Care Med. 2023 Aug;38(8):751-759. doi: 10.1177/08850666231162805. Epub 2023 Mar 20.
It is known that patients with COVID-19 are at high risk of developing delirium. The aim of the study was to compare the incidence of delirium between critically ill patients with and without a diagnosis of COVID-19.
This is a retrospective study conducted in a southern Brazilian hospital from March 2020 to January 2021. Patients were divided into two groups: the COVID-19 group consisted of patients with a diagnosis of COVID-19 confirmed by reverse transcription-polymerase chain reaction (RT-PCR) or serological tests who were admitted to specific ICUs. The non-COVID-19 group consisted of patients with other surgical and medical diagnoses who were admitted to non-COVID ICUs. All patients were evaluated daily using the Intensive Care Delirium Screening Checklist (ICDSC). The two cohorts were compared in terms of the diagnosis of delirium.
Of the 649 patients who remained more than 48 h in the ICU, 523 were eligible for the study (COVID-19 group: 292, non-COVID-19 group: 231). There were 119 (22.7%) patients who had at least one episode of delirium, including 96 (32.9%) in the COVID-19 group and 23 (10.0%) in the non-COVID-19 group (odds ratio [OR] 4.42; 95% confidence interval [CI], 2.69 to 7.26; p < 0.001). Among patients mechanically ventilated for two days or more, the incidence of delirium did not differ between groups (COVID-19: 89/211, 42.1% vs non-COVID-19: 19/47, 40.4%; p = 0.82). Logistic regression showed that the duration of mechanical ventilation was the only independent factor associated with delirium (p = 0.001).
COVID-19 can be associated with a higher incidence of delirium among critically ill patients, but there was no difference in this incidence between groups when mechanical ventilation lasted two days or more.
已知 COVID-19 患者发生谵妄的风险较高。本研究旨在比较确诊和未确诊 COVID-19 的危重症患者谵妄的发生率。
这是一项回顾性研究,在巴西南部的一家医院进行,时间为 2020 年 3 月至 2021 年 1 月。患者分为两组:COVID-19 组由通过逆转录-聚合酶链反应(RT-PCR)或血清学检测确诊 COVID-19 并收治在特定 ICU 的患者组成。非 COVID-19 组由收治在非 COVID-19 ICU 的其他外科和内科诊断患者组成。所有患者均每日使用重症监护谵妄筛查检查表(ICDSC)进行评估。比较两组谵妄的诊断。
在 ICU 停留超过 48 小时的 649 名患者中,523 名符合研究条件(COVID-19 组:292 名,非 COVID-19 组:231 名)。共有 119 名(22.7%)患者至少发生过一次谵妄,其中 COVID-19 组 96 例(32.9%),非 COVID-19 组 23 例(10.0%)(比值比 [OR] 4.42;95%置信区间 [CI],2.69 至 7.26;p<0.001)。对于机械通气两天或以上的患者,两组谵妄发生率无差异(COVID-19:211 例中有 89 例,42.1%;非 COVID-19:47 例中有 19 例,40.4%;p = 0.82)。Logistic 回归显示,机械通气时间是唯一与谵妄相关的独立因素(p = 0.001)。
COVID-19 可能与危重症患者谵妄发生率较高相关,但机械通气持续两天或以上时,两组间谵妄发生率无差异。